Quantcast
Last updated on April 17, 2014 at 14:25 EDT

Latest Clinical trial Stories

2014-03-19 16:23:55

BUFFALO, N.Y., March 19, 2014 /PRNewswire/ -- Kinex Pharmaceuticals announced today to having received regulatory and ethics approvals to initiate the first clinical study of an oral form of paclitaxel (Oraxol) in Dunedin Hospital in Otago, New Zealand. This is the first clinical study of Oraxol in New Zealand. Oraxol is also currently in clinical studies conducted in Korea and in the United States of America. Dr. Rudolf Kwan, Chief Medical Officer of Kinex stated "Kinex is...

2014-03-19 08:29:11

SAN DIEGO, March 19, 2014 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC) a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced FDA clearance of its proprietary instant wave-Free Ratio(TM) or iFR(®) Modality. The iFR(®) Modality is a physiologic measurement performed using the same pressure wires and equipment utilized in cath labs for Fractional Flow...

2014-03-19 08:28:22

Increases global capacity and adds new secondary packaging and labeling services to more efficiently deliver clinical trial supplies BOSTON, March 19, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the expansion of its global Clinical Logistics Services (CLS) capabilities. A new, state-of-the-art distribution center in Singapore and the recent expansion of the Company's facilities in...

2014-03-18 08:33:42

New Board Will Advise Mytrus On Developing Innovative New Products Essential For Improving Research and the Patient Experience in Clinical Trials BURLINGTON, Mass., March 18, 2014 /PRNewswire/ --inVentiv Health, a life science knowledge and services company for the new healthcare environment, announced today the creation of a new Innovation Advisory Board comprised of leading industry experts who will help shape the future of clinical products and services offered by Mytrus, a...

2014-03-18 08:26:31

LONDON, March 18, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Liver Transplantation Global Clinical Trials Review, H2, 2013 Liver Transplantation Global Clinical Trials Review, H2, 2013SummaryGlobalData's clinical trial report, "Liver Transplantation Global Clinical Trials Review, H2, 2013" provides data on the Liver Transplantation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on...

2014-03-17 23:24:53

The MSA Coalition® announced in January 2014 the funding of five MSA research grants for a total of $219,000 including the "Global MSA Registry & Study Group.” The project is being led by researchers from Austria and the USA and will facilitate future international MSA trial recruitment and promote sharing of anonymous patient information to identify the natural history of multiple system atrophy (MSA). New York, New York (PRWEB) March 17, 2014 The Multiple System Atrophy...

2014-03-17 16:28:46

Expanding Cancer Monitoring Platform with Additional Oncogene Mutation Assays, Building Clinical Evidence to Facilitate Broad Adoption SAN DIEGO, March 17, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today reported its financial results for the quarter and the year ended December 31, 2013. http://photos.prnewswire.com/prnvar/20120620/LA28014LOGO "In 2013, we transitioned from a technology-driven company to one focused on building a body...

2014-03-16 23:00:43

Purdue University and Houston Methodist Research Institute plan to collaborate on research and educational initiatives, including clinical trials of drugs developed at Purdue. West Lafayette, IN (PRWEB) March 16, 2014 Purdue University and Houston Methodist Research Institute plan to collaborate on research and educational initiatives, including clinical trials of drugs developed at Purdue. The partnership helps to advance the Purdue Moves drug discovery initiative to translate basic...

2014-03-14 12:28:25

WCCT Global Announces their attendance at the 1024 ASCPT Event at Booth #600 COSTA MESA, Calif., March 14, 2014 /PRNewswire-iReach/ -- WCCT Global, a full-service CRO headquartered in Southern California announced today that they will be in attendance at the 2014 ASCPT event in Atlanta, Georgia. WCCT Global is pleased to be in attendance at this event because the company has expanded with multiple new service offerings including influenza challenge and ophthalmology research...

2014-03-13 23:27:22

JDP Therapeutics Inc., a privately held specialty pharmaceutical company, is pleased to announce that the Company’s Investigational New Drug (IND) to conduct an initial Phase 3 clinical trial of JDP-205 in patients with acute urticaria associated with an acute allergic reaction has been cleared by the U.S. Food and Drug Administration (FDA). Blue Bell, PA (PRWEB) March 13, 2014 JDP Therapeutics Inc., a privately held specialty pharmaceutical company, is pleased to announce that the...